Drugs like Ozempic, Wegovy, and Mounjaro are not just treatmentsthey represent a major shift toward hormone-based, targeted therapy
If you are already experiencing symptoms at the starting dose, increasing will make them worse
Sustainable Weight Management Semaglutide and Tirzepatide support long-term weight management by promoting sustainable lifestyle changes and healthy habits Who is the Best Candidate for Semaglutide and Tirzepatide
Yet, these concerns overlook: cost offsets associated with prevented complications decrease in net prices as more agents enter the market Medicare price negotiation (if Ozempic is negotiated, as expected, Wegovy would automatically be subject to negotiation if it was covered under Part D) future entry of generics Public funding should not be used to support treatment given personal responsibility
Prepared under pharmacy-compounding standards
Semin Cutan Med Surg 2010 Dec;29(4):204-9 Available from: Jhappan C, Noonan FP, Merlino G